Related references
Note: Only part of the references are listed.Recent advances in the diagnosis and management of giant cell arteritis
Naomi Serling-Boyd et al.
CURRENT OPINION IN RHEUMATOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
PGE2 enhanced TNFα-mediated IL-8 induction in monocytic cell lines and PBMC
F. Neuschaefer-Rube et al.
CYTOKINE (2019)
Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor to gp130 expression: fusing experimental insights and dynamic modelling
Heike Reeh et al.
CELL COMMUNICATION AND SIGNALING (2019)
Expression of human inducible nitric oxide synthase in response to cytokines is regulated by hypoxia-inducible factor-1
Martin Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells
Mulugeta M. Zegeye et al.
CELL COMMUNICATION AND SIGNALING (2018)
IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane
Rusan Catar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade
Stanley C. Jordan et al.
TRANSPLANTATION (2017)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation
Stefan Rose-John
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
MicroRNAs Regulate Cytokine Responses in Gingival Epithelial Cells
Steven C. Y. Chen et al.
INFECTION AND IMMUNITY (2016)
Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling
Janina Wolf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Graft-Derived IL-6 Amplifies Proliferation and Survival of Effector T Cells That Drive Alloimmune-Mediated Vascular Rejection
Anna von Rossum et al.
TRANSPLANTATION (2016)
Interleukin-6: Biology, signaling and strategies of blockade
Fred Schaper et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
A Phase I/II Trial of the Interleukin-6 Receptor Specific Humanized Monoclonal (Tocilizumab) plus Intravenous Immunoglobulin in Difficult to Desensitize Patients
Ashley A. Vo et al.
TRANSPLANTATION (2015)
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Winnie Enns et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Bim Regulates Alloimmune-Mediated Vascular Injury Through Effects on T-Cell Activation and Death
Anna von Rossum et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Inhibition of IL-6 family cytokines by SOCS3
Jeffrey J. Babon et al.
SEMINARS IN IMMUNOLOGY (2014)
Interleukin-6 Trans-Signaling Exacerbates Inflammation and Renal Pathology in Lupus-Prone Mice
Evelyn Tsantikos et al.
ARTHRITIS AND RHEUMATISM (2013)
Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Harald Schuett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Induction of Endothelial Nitric Oxide Synthase Expression by IL-17 in Human Vascular Endothelial Cells: Implications for Vascular Remodeling in Transplant Vasculopathy
Arthur C. Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
CD155 on Human Vascular Endothelial Cells Attenuates the Acquisition of Effector Functions in CD8 T Cells
Nichole K. Escalante et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling
Sven Malchow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)
Karen M. Henkels et al.
FEBS LETTERS (2011)
Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
IFNγ-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells
Hans A. R. Bluyssen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
Michihisa Jougasaki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Loss of CD4+ T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells
Gareth W. Jones et al.
JOURNAL OF IMMUNOLOGY (2010)
Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation
Prodyot K. Chatterjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Interleukin-6 Maintains Bone Marrow-Derived Mesenchymal Stem Cell Stemness by an ERK1/2-Dependent Mechanism
Katie L. Pricola et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
Mari A. Nowell et al.
JOURNAL OF IMMUNOLOGY (2009)
Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130
Stephanie Tenhumberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Bjorn Rabe et al.
BLOOD (2008)
Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization
Kanako Izumi-Nagai et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Stat3 mediates interelukin-6 inhibition of human endothelial nitric-oxide synthase expression
Marta Saura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory t cells
HH Oberg et al.
INTERNATIONAL IMMUNOLOGY (2006)
Signal transducer and activator of transcription 3α and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium
XP Yang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow
CW Ni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells
V Iourgenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H2O2-induced cell death
AB Waxman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice
ZQ Lin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line
Y To et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
L Terstegen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)